The AIRAscore structure software uses the latest technical possibilities and measures the brain volume and its changes on the basis of MRI image data of the head.
The result is an evaluation report with precise measured values of various brain structures that are important for diagnostics.
Your doctor can use these objective measured and comparative values for his findings like a kind of ‘second opinion’ and incorporate them into his diagnosis.
Early diagnosis, better and more reliable differential diagnoses as well as individual therapies are thus made easier – or even possible in the first place.
More options for diagnostic findings – highlights of our evaluation report
You too can benefit from the innovative possibilities in differential diagnosis. AIRAscore structure supports the purely visual diagnosis of your doctor with expertise from top university research.
The technology behind it explained in simple terms
MRI images of your brain
Suitable MRI image data are the basis of every evaluation.
They show layers of your brain – several hundred at intervals of about 1 mm. You can imagine this roughly like a flip book.
On each sheet you can see a frame of the ‘film’, but only the sequence results in the actual cinema film. Or in this case – a complete brain.
Breakdown into voxels
At the beginning of the analysis, each of these layers is divided into a grid of cubes –
so-called voxels.
Each voxel is about 1 mm³ in size; for example, one voxel of the cerebral cortex contains about 90,000 nerve cells! This also explains why even small changes in volume are so important for a diagnosis!
Segmentation and measurement
The software assigns the voxels to the individual brain structures. This is called segmentation.
The volume of the individual segments is then determined on the basis of this assignment.
Comparison with healthy reference values
Taking into account individual parameters such as gender, age and head size, we check whether your measurement results are within the normal range.
Depending on whether there are deviations – also to what extent and within which structures – your doctor will have important indications of a disease.
We provide all evaluation results in a clear report. Accurate follow-up examinations are thus easily possible.
Use AIRAscore software solutions!
More and more doctors are using AIRAmed software solutions. Speak to your doctor about it! Or get in touch with us! We will be happy to provide you with information on which practice or clinic in your area is already using the evaluation possibilities of AIRAmed.
Do you already have suitable MRI data? Contact us. We will arrange the evaluation directly!
An excerpt of our references
‘Especially in the case of rare neurological diseases, we are often faced with the problem of whether an individual brain scan is already conspicuous or not. AIRAscore provides great help in our daily work.’
Prof. Dr. Ludger Schöls
Neurologist, University Hospital of Tübingen, Germany
‘I am pleased to be able to offer my patients the additional service provided by AIRAscore. Experience shows that very many patients are afraid of dementia in old age. AIRAscore helps me to distinguish healthy from sick aging and I recognize much earlier than with the pure visual findings whether and when concrete action is needed.’
Dr. Nicola Meyer
Radiologist, Hamburg, Germany
‘I am pleased that with AIRAscore structure we now have a way to benefit from the latest scientific findings in our private practice. It only takes a few minutes until I have exact measurement values directly in my PACS, which significantly improve my reporting options.’
PD Dr. Hansjörg Rempp
Radiologist, Stuttgart, Germany
‘The quantitative assessment of brain volume is becoming increasingly important. Objectively verifiable measured values are the basis for any personalised treatment tailored to the individual patient. AIRAmed fills this gap in personalised healthcare through machine learning.’
Prof. Dr. Matthis Synofzik
Neurologist, University Hospital of Tübingen, Germany
‘We now use AIRAscore structure routinely with our inpatients. The findings report gives us the necessary security here in the assessment of dementia-related diseases.’
Prof. Dr. Gerhard Eschweiler
Psychiatrist, University Hospital of Tübingen, Germany